Sen. Warren, Novo At Odds On Merits Of $16.5B Deal
By Al Barbarino · October 10, 2024, 4:30 PM EDT
Sen. Elizabeth Warren on Thursday raised the alarm on Novo Holdings' planned $16.5 billion purchase of Catalent, arguing the transaction could give Novo "unprecedented" control over the production of certain obesity...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login